Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease

MLA

Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center], et al. Mitochondrial DNA Heteroplasmy Distinguishes Disease Manifestation in PINK1/PRKN-Linked Parkinson’s Disease. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1372648172&authtype=sso&custid=ns315887.

APA

Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center], Luxembourg Centre for Systems Biomedicine (LCSB) [research center], Fonds National de la Recherche - FnR, P. M. [sponsor], DFG (ProtectMove) [sponsor], BMBF (MitoPD) [sponsor], Trinh, J., Hicks, A. A., König, I. R., Delcambre, S., Lüth, T., Schaake, S., Wasner, K., Ghelfi, J., Borsche, M., Vilariño-Güell, C., Hentati, F., Germer, E. L., Bauer, P., Takanashi, M., … Grünewald, A. (2023). Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease.

Chicago

Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center], Luxembourg Centre for Systems Biomedicine (LCSB) [research center], ProtectMove, MiRisk) [sponsor] Fonds National de la Recherche - FnR, DFG (ProtectMove) [sponsor], BMBF (MitoPD) [sponsor], Joanne Trinh, Andrew A. Hicks, et al. 2023. “Mitochondrial DNA Heteroplasmy Distinguishes Disease Manifestation in PINK1/PRKN-Linked Parkinson’s Disease.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1372648172&authtype=sso&custid=ns315887.